Vav1 and mutant K-Ras synergize in the early development of pancreatic ductal adenocarcinoma in mice

Yaser Salaymeh; Marganit Farago; Shulamit Sebban; Batel Shalom; Eli Pikarsky; Shulamit Katzav

doi:10.26508/lsa.202000661

Research Article

Open Access

Vav1 and mutant K-Ras synergize in the early development of pancreatic ductal adenocarcinoma in mice

Yaser Salaymeh, Marganit Farago, Shulamit Sebban, Batel Shalom, Eli Pikarsky, View ORCID ProfileShulamit Katzav Correspondence email

Yaser Salaymeh

1Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, The Hebrew University Hadassah Medical School, Jerusalem, Israel

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marganit Farago

1Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, The Hebrew University Hadassah Medical School, Jerusalem, Israel

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Shulamit Sebban

1Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, The Hebrew University Hadassah Medical School, Jerusalem, Israel

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Batel Shalom

1Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, The Hebrew University Hadassah Medical School, Jerusalem, Israel

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Eli Pikarsky

2The Lautenberg Center for Immunology and Cancer Research and Department of Pathology, Institute for Medical Research Israel-Canada, The Hebrew University Hadassah Medical School, Jerusalem, Israel

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Shulamit Katzav

1Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, The Hebrew University Hadassah Medical School, Jerusalem, Israel

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Shulamit Katzav
For correspondence: shulamitk@ekmd.huji.ac.il

Published 10 April 2020. DOI: 10.26508/lsa.202000661

Article
Figures & Data
Info
Metrics
Reviewer Comments
PDF

Statistics from Altmetric.com

Article usage

Article usage: April 2020 to January 2022

	Abstract	Full	Pdf
Apr 2020	31	290	171
May 2020	8	81	62
Jun 2020	12	47	45
Jul 2020	5	108	21
Aug 2020	4	122	19
Sep 2020	3	55	17
Oct 2020	3	53	44
Nov 2020	3	69	24
Dec 2020	1	64	13
Jan 2021	4	36	22
Feb 2021	2	30	18
Mar 2021	2	50	20
Apr 2021	3	66	14
May 2021	3	181	17
Jun 2021	2	45	30
Jul 2021	2	22	15
Aug 2021	2	27	7
Sep 2021	3	18	16
Oct 2021	0	47	35
Nov 2021	1	35	28
Dec 2021	0	39	22
Jan 2022	2	27	24

Cited By...

1 Citations
Google Scholar

PreviousNext

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Life Science Alliance.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Vav1 and mutant K-Ras synergize in the early development of pancreatic ductal adenocarcinoma in mice

Message Subject (Your Name) has sent you a message from Life Science Alliance

Message Body (Your Name) thought you would like to see the Life Science Alliance web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Synergy: Vav1 and KRas^G12D in mouse PDAC